Alivus Life Sciences Ltd.

Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glenmark Life Sciences has informed that the company has have uploaded audio recording of the Q4 & FY22 Earnings Call held on April 21, 2022, on its investor website: https://www.glenmarklifesciences.com/financial-results.php under Financial Results.

The above information is a part of company’s filings submitted to BSE.